Literature DB >> 7218004

Fibrinolytic activity of plaques and white matter in multiple sclerosis.

H E Hirsch, C E Blanco, M E Parks.   

Abstract

Recent work has implicated plasminogen activator released from macrophages as a possible mediator of the demyelinating process in experimental allergic encephalomyelitis and multiple sclerosis (MS). We have studied the capacity of white matter and plaques from MS patients to break down fibrin clots, using a histochemical technique. Fibrinolytic activity was localized exclusively to areas around blood vessels and capillaries in both patients and controls. While there was marked variation between individuals, the unaffected white matter from MS patients was, on the average, not more active than that of controls, but plaques tended to show more numerous foci of lysis, often also more intense, than adjacent white matter; there was no correlation with disease activity or age of the plaques as determined by histological criteria. The localization and degree of fibrinolysis observed were not related to the presence of lymphocytic infiltrates, gliosis, or macrophages. However, the findings do not exclude an involvement of fibrinolytic enzymes (although originating from vascular endothelium rather than macrophages) in the genesis of the MS plaque, which commonly starts around a small vein.

Entities:  

Mesh:

Year:  1981        PMID: 7218004     DOI: 10.1097/00005072-198105000-00005

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  9 in total

Review 1.  Proteinases in inflammatory demyelinating disease.

Authors:  C T Bever; J N Whitaker
Journal:  Springer Semin Immunopathol       Date:  1985

Review 2.  Proteases of human brain.

Authors:  A Pope; R A Nixon
Journal:  Neurochem Res       Date:  1984-03       Impact factor: 3.996

3.  Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.

Authors:  Ya Zhang; Xiaomei Zhang; Dongsheng Liu; Honghao Wang; Suyue Pan; Dongmei Wang; Xiong Chen
Journal:  Neurol Sci       Date:  2016-07-23       Impact factor: 3.307

4.  Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.

Authors:  Katerina Akassoglou; Ryan A Adams; Jan Bauer; Peter Mercado; Vivian Tseveleki; Hans Lassmann; Lesley Probert; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

5.  Factors restricting maximal preservation of neuronal glycogen after perfusion fixation with dimethyl sulfoxide and iodoacetic acid in Bouin's solution. Histochemical observations in the brain of the Netherlands dwarf rabbit.

Authors:  J Cammermeyer; I M Fenton
Journal:  Histochemistry       Date:  1982

6.  Fibronectin in multiple sclerosis lesions.

Authors:  R A Sobel; M E Mitchell
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

7.  Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis.

Authors:  M E Smith; L A Amaducci
Journal:  Neurochem Res       Date:  1982-05       Impact factor: 3.996

Review 8.  Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.

Authors:  Nicole Ziliotto; Francesco Bernardi; Dejan Jakimovski; Robert Zivadinov
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

9.  Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?

Authors:  Bernd Krone; John M Grange
Journal:  BMC Neurol       Date:  2013-07-18       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.